Bicycle Therapeutics (BCYC) Interest Expenses (2021 - 2026)
Bicycle Therapeutics (BCYC) reported Interest Expenses of $48000.0 for Q1 2026, down 5.88% on a YoY basis from $51000.0 in Q1 2025, and down 15.79% quarter-over-quarter from $57000.0 in Q4 2025.
Bicycle Therapeutics (BCYC) Interest Expenses (2021 - 2026) Analysis & Trends
Bicycle Therapeutics has reported Interest Expenses for 6 years, with the latest figure at $48000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses fell 5.88% year-over-year to $48000.0; the trailing twelve-month figure through Mar 2026 stood at $203000.0 (down 78.85% YoY), and the FY2025 full-year result was $206000.0, down 88.09% from the prior year.
- Interest Expenses for Q1 2026 stood at $48000.0, down from $57000.0 in the prior quarter.
- The five-year high for Interest Expenses was $883000.0 in Q2 2022, with the low at $33000.0 in Q3 2024.
- Historically, Interest Expenses has averaged $505352.9 across 5 years, with a median of $814000.0 in 2023.
- Annual changes were most pronounced in 2022 — Interest Expenses jumped 56.7% — and 2024, when it slumped 95.95%.
- Bicycle Therapeutics' Interest Expenses stood at $826000.0 in 2022, then declined by 0.73% to $820000.0 in 2023, then plunged by 93.66% to $52000.0 in 2024, then climbed by 9.62% to $57000.0 in 2025, then slipped by 15.79% to $48000.0 in 2026.
- The last three Interest Expenses figures came in at $48000.0 (Q1 2026), $57000.0 (Q4 2025), and $44000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Bicycle Therapeutics | 278.04 Mn | 278.04 Mn | - | 48,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48,000.00 |
| Mar 31, 2026 | 48,000.00 |
| Dec 31, 2025 | 57,000.00 |
| Dec 31, 2025 | 57,000.00 |
| Sep 30, 2025 | 44,000.00 |
| Sep 30, 2025 | 44,000.00 |
| Jun 30, 2025 | 54,000.00 |
| Jun 30, 2025 | 54,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Dec 31, 2024 | 52,000.00 |
| Dec 31, 2024 | 52,000.00 |
| Sep 30, 2024 | 33,000.00 |
| Sep 30, 2024 | 33,000.00 |
| Jun 30, 2024 | 824,000.00 |
| Jun 30, 2024 | 824,000.00 |
| Mar 31, 2024 | 821,000.00 |
| Mar 31, 2024 | 821,000.00 |
| Dec 31, 2023 | 820,000.00 |
| Dec 31, 2023 | 820,000.00 |